HealthTronics President and CEO James Whittenburg to Present at UBS Global Healthcare Conference February 11, 2008

  
    
  
  
    
      HealthTronics, Inc. (NASDAQ:HTRN), today announced that James 
      Whittenburg, President and CEO will be presenting at the UBS Global 
      Healthcare Conference in New York City, NY at the Grand Hyatt Hotel on 
      Monday, February 11, 2008 at 8:00 a.m. Eastern time.
    
    
      The presentation will be recorded live and be available by replay three 
      hours after the actual presentation time or 11:00 a.m. Eastern time. To 
      access the link, go to www.healthtronics.com 
      and click on the Investors tab. The presentation will be available on 
      the website until March 14, 2008.
    
    
      About HealthTronics, Inc.
    
    
      HealthTronics provides healthcare services, primarily to the urology 
      community, and manufactures medical devices as well as specialty 
      vehicles used for the transport of high technology medical and broadcast 
      & communications equipment. For more information, visit www.healthtronics.com.
    
    
      Statements by the Company’s management 
      during the conference call announced in this press release that are not 
      strictly historical, including statements regarding plans, objective and 
      future financial performance, are “forward-looking” 
      statements that are made pursuant to the safe harbor provisions of the 
      Private Securities Litigation Reform Act of 1995. Although 
      HealthTronics believes that the expectations reflected in such 
      forward-looking statements are reasonable, no assurance can be given 
      that the expectations will prove to be correct. Factors that 
      could cause actual results to differ materially from HealthTronics’ 
      expectations include, among others, the existence of demand for and 
      acceptance of HealthTronics’ services, the 
      integration of Prime’s and HealthTronics’ 
      businesses, regulatory approvals, economic conditions, the impact of 
      competition and pricing, financing efforts and other factors described 
      from time to time in HealthTronics’ periodic 
      filings with the Securities and Exchange Commission.